Synapse

← Nikolaos Dagres

Papers by Nikolaos Dagres

Page 3 · newest first

  1. Cardiovascular magnetic resonance-based predictors of complete left ventricular systolic functional recovery after rhythm restoration in patients with atrial tachyarrhythmiaEP Europace · 2021
  2. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophyScientific Reports · 2021
  3. Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationaleBiomedical Papers · 2021
  4. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial FibrillationEP Europace · 2021
  5. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2021
  6. [2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].2021
  7. VT ablation in geriatric patients with structural heart disease: Should there still be an age limit?Journal of Cardiovascular Electrophysiology · 2021
  8. Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?Clinical Cardiology · 2020
  9. Validation of the VT‐LVAD score for prediction of late VAs in LVAD recipientsJournal of Cardiovascular Electrophysiology · 2020
  10. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS)EP Europace · 2020
  11. Transvenous revision of leads with cardiac perforation following device implantation—Safety, outcome, and complicationsPacing and Clinical Electrophysiology · 2020
  12. The PROFID projectEuropean Heart Journal · 2020
  13. Quality indicators for the care and outcomes of adults with atrial fibrillationEP Europace · 2020
  14. Impact of centre volume on atrial fibrillation ablation outcomes in Europe: a report from the ESC EHRA EORP Atrial Fibrillation Ablation Long-Term (AFA LT) RegistryEP Europace · 2020
  15. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Heart Journal · 2020
  16. Knowledge gaps, lack of confidence, and system barriers to guideline implementation among European physicians managing patients with CIED lead or infection complications: a European Heart Rhythm Association/European Society of Cardiology educational needs assessment surveyEP Europace · 2020
  17. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right populationHeart Rhythm · 2020
  18. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right populationJournal of Arrhythmia · 2020
  19. Predictors of long-term mortality after catheter ablation of ventricular tachycardia in a contemporary cohort of patients with structural heart diseaseEP Europace · 2020
  20. Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2020
  21. Myocardial infarction or acute coronary syndrome with non-obstructive coronary arteries and sudden cardiac death: a missing connectionEP Europace · 2020
  22. Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional DefibrillatorApplied Health Economics and Health Policy · 2020
  23. Impact of single versus double transseptal puncture on outcome and complications in pulmonary vein isolation proceduresCardiology Journal · 2020
  24. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right populationEP Europace · 2020
  25. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE VDiabetes Care · 2020
  26. Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot SurveyEP Europace · 2020
  27. Role of inducibility and its dynamic change in the outcome of catheter ablation of atrial fibrillation: a single center prospective studyJournal of Cardiovascular Electrophysiology · 2020
  28. Factors influencing the use of leadless or transvenous pacemakers: results of the European Heart Rhythm Association Prospective SurveyEP Europace · 2020
  29. Atrial fibrillation: is there a role for cardiac troponin?Diagnosis · 2020
  30. Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptomsJournal of Cardiovascular Magnetic Resonance · 2020
  31. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based surveyEP Europace · 2019
  32. Ablation strategies for different types of atrial fibrillation in Europe: results of the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registryEP Europace · 2019
  33. Which patients with atrial fibrillation undergo an ablation procedure today in Europe? A report from the ESC-EHRA-EORP Atrial Fibrillation Ablation Long-Term and Atrial Fibrillation General Pilot RegistriesEP Europace · 2019
  34. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)European Journal of Cardio-Thoracic Surgery · 2019
  35. Letter by Sepehri Shamloo et al Regarding Article, “Atrial Fibrillation Catheter Ablation Improves 1-Year Follow-Up Cognitive Function, Especially in Patients with Impaired Cognitive Function”Circulation Arrhythmia and Electrophysiology · 2019
  36. Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications?EP Europace · 2019
  37. Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registryEP Europace · 2019
  38. The electrocardiogram endeavour: from the Holter single-lead recordings to multilead wearable devices supported by computational machine learning algorithms日本内科学会雑誌 · 2019
  39. Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trialsEP Europace · 2019
  40. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections—endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)EP Europace · 2019
  41. Educational needs among physicians treating patients with atrial fibrillation: lessons for Poland from the European Society of Cardiology international educational needs assessment studyPolskie Archiwum Medycyny Wewnętrznej · 2019
  42. Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation RegistryEP Europace · 2019
  43. In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registry: sex differencesEP Europace · 2019
  44. Influence of risk factors in the ESC‐EHRA EORP atrial fibrillation ablation long‐term registryPacing and Clinical Electrophysiology · 2019
  45. ‘Real-world’ observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS)EP Europace · 2019
  46. Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registryEP Europace · 2019
  47. Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyInternational Journal of Sports Medicine · 2019
  48. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA)EP Europace · 2019
  49. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm AssociationEP Europace · 2019
  50. EHRA White Paper: knowledge gaps in arrhythmia management—status 2019EP Europace · 2019